New technology and innovation may help turn the corner on antibiotic resistance.
Brian Finrow, JD
Advertisement
Brian Finrow, JD, is founder and CEO of Lumen Bioscience, a clinical-stage biotechnology company in Seattle.
Articles by Brian Finrow, JD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Young Women With Symptomatic Long COVID At Higher Risk of POTS
2
GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders
3
Breaking News: CVS Buys Rite Aid, Bartell Drugs
4
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
5
